Home/Filings/4/0001732701-25-000007
4//SEC Filing

MCDONOUGH GEOFF 4

Accession 0001732701-25-000007

CIK 0001733294other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 5:00 PM ET

Size

11.2 KB

Accession

0001732701-25-000007

Insider Transaction Report

Form 4
Period: 2025-10-31
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-31+659137,495 total
  • Tax Payment

    Common Stock

    2025-10-31$5.51/sh293$1,614137,202 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-316591,977 total
    Common Stock (527 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    22,646
  • Common Stock

    (indirect: By Trust)
    27,500
Footnotes (5)
  • [F1]Reflects an acceleration of vesting due to the reporting person's resignation as the Issuer's Chief Executive Officer & President.
  • [F2]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F3]The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust.
  • [F4]The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.
  • [F5]On January 20, 2023, the reporting person was granted 8,437 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001732701

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:00 PM ET
Size
11.2 KB